Skip to main content
Top
Published in: Clinical Rheumatology 7/2016

Open Access 01-07-2016 | Original Article

Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay

Authors: Atul Deodhar, Manish Mittal, Patrick Reilly, Yanjun Bao, Shivaji Manthena, Jaclyn Anderson, Avani Joshi

Published in: Clinical Rheumatology | Issue 7/2016

Login to get access

Abstract

This study aimed to identify providers involved in diagnosing ankylosing spondylitis (AS) following back pain diagnosis in the USA and to identify factors leading to the delay in rheumatology referrals. The Truven Health MarketScan® US Commercial Database was searched for patients aged 18–64 years with back pain diagnosis in a non-rheumatology setting followed by AS diagnosis in any setting during January 2000–December 2012. Patients with a rheumatologist visit on or before AS diagnosis were considered referred. Cox regression was used to determine factors associated with referral time after adjusting for age, sex, comorbidities, physician specialty, drug therapy, and imaging procedures. Of 3336 patients included, 1244 (37 %) were referred to and diagnosed by rheumatologists; the others were diagnosed in primary care (25.7 %), chiropractic/physical therapy (7 %), orthopedic surgery (3.8 %), pain clinic (3.6 %), acute care (3.4 %), and other (19.2 %) settings. Median time from back pain diagnosis to rheumatology referral was 307 days and from first rheumatologist visit to AS diagnosis was 28 days. Referred patients were more likely to be younger (hazard ratio [HR] = 0.986; p < 0.0001), male (HR = 1.15; p = 0.0163), diagnosed with uveitis (HR = 1.49; p = 0.0050), referred by primary care physicians (HR = 1.96; p < 0.0001), prescribed non-steroidal anti-inflammatory drugs (HR = 1.55; p < 0.0001), disease-modifying antirheumatic drugs (HR = 1.33; p < 0.0001), and tumor necrosis factor inhibitors (HR = 1.40; p = 0.0036), and to have had spinal/pelvic X-ray prior to referral (HR = 1.28; p = 0.0003). During 2000–2012, most patients with AS were diagnosed outside of rheumatology practices. The delay before referral to rheumatology was 10 months; AS diagnosis generally followed within a month. Earlier referral of patients with AS signs and symptoms may lead to more timely diagnosis and appropriate treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Collantes E, Zarco P, Muñoz E, Juanola X, Mulero J, Fernández-Sueiro JL et al (2007) Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report. Rheumatology (Oxford) 46:1309–1315CrossRef Collantes E, Zarco P, Muñoz E, Juanola X, Mulero J, Fernández-Sueiro JL et al (2007) Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report. Rheumatology (Oxford) 46:1309–1315CrossRef
2.
go back to reference Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66PubMed Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66PubMed
3.
go back to reference Feldtkeller E, Erlendsson J (2008) Definition of disease duration in ankylosing spondylitis. Rheumatol Int 28:693–696CrossRefPubMed Feldtkeller E, Erlendsson J (2008) Definition of disease duration in ankylosing spondylitis. Rheumatol Int 28:693–696CrossRefPubMed
4.
go back to reference Deodhar A, Mease PJ, Reveille JD, Curtis JR, Karunaratne PM, Malhotra K et al (2014) Prevalence of axial spondyloarthritis among undiagnosed chronic back pain patients in the United States [abstract]. Ann Rheum Dis 73(Suppl 2):198–199CrossRef Deodhar A, Mease PJ, Reveille JD, Curtis JR, Karunaratne PM, Malhotra K et al (2014) Prevalence of axial spondyloarthritis among undiagnosed chronic back pain patients in the United States [abstract]. Ann Rheum Dis 73(Suppl 2):198–199CrossRef
6.
go back to reference Rudwaleit M, Sieper J (2012) Referral strategies for early diagnosis of axial spondyloarthritis [review]. Nat Rev Rheumatol 8:262–268CrossRefPubMed Rudwaleit M, Sieper J (2012) Referral strategies for early diagnosis of axial spondyloarthritis [review]. Nat Rev Rheumatol 8:262–268CrossRefPubMed
7.
go back to reference Sieper J, Rudwaleit M (2005) Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care [review]. Ann Rheum Dis 64:659–663CrossRefPubMed Sieper J, Rudwaleit M (2005) Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care [review]. Ann Rheum Dis 64:659–663CrossRefPubMed
8.
go back to reference Kotsis K, Voulgari PV, Drosos AA, Carvalho AF, Hyphantis T (2014) Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review [review]. Expert Rev Pharmacoecon Outcomes Res 14:857–872CrossRefPubMed Kotsis K, Voulgari PV, Drosos AA, Carvalho AF, Hyphantis T (2014) Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review [review]. Expert Rev Pharmacoecon Outcomes Res 14:857–872CrossRefPubMed
9.
go back to reference van den Berg R, Baraliakos X, Braun J, van der Heijde D (2012) First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis [review]. Rheumatology (Oxford) 51:1388–1396CrossRef van den Berg R, Baraliakos X, Braun J, van der Heijde D (2012) First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis [review]. Rheumatology (Oxford) 51:1388–1396CrossRef
10.
go back to reference van der Heijde D, Breban M, Halter D, DiVittorio G, Bratt J, Cantini F et al (2015) Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab. Rheumatology (Oxford) 54:1210–1219CrossRef van der Heijde D, Breban M, Halter D, DiVittorio G, Bratt J, Cantini F et al (2015) Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab. Rheumatology (Oxford) 54:1210–1219CrossRef
11.
go back to reference Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904CrossRefPubMedPubMedCentral Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904CrossRefPubMedPubMedCentral
12.
go back to reference Deyo RA, Tsui-Wu YJ (1987) Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine (Phila Pa 1976) 12:264–268CrossRef Deyo RA, Tsui-Wu YJ (1987) Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine (Phila Pa 1976) 12:264–268CrossRef
13.
go back to reference Carey TS, Freburger JK, Holmes GM, Jackman A, Knauer S, Wallace A et al (2010) Race, care seeking, and utilization for chronic back and neck pain: population perspectives. J Pain 11:343–350CrossRefPubMed Carey TS, Freburger JK, Holmes GM, Jackman A, Knauer S, Wallace A et al (2010) Race, care seeking, and utilization for chronic back and neck pain: population perspectives. J Pain 11:343–350CrossRefPubMed
14.
go back to reference Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P, Clinical Efficacy Assessment Subcommittee of the American College of Physicians; American College of Physicians; American Pain Society Low Back Pain Guidelines Panel et al (2007) Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 147:478–491CrossRefPubMed Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P, Clinical Efficacy Assessment Subcommittee of the American College of Physicians; American College of Physicians; American Pain Society Low Back Pain Guidelines Panel et al (2007) Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 147:478–491CrossRefPubMed
15.
go back to reference Herndon CM, Zoberi KS, Gardner BJ (2015) Common questions about chronic low back pain. Am Fam Physician 91:708–714PubMed Herndon CM, Zoberi KS, Gardner BJ (2015) Common questions about chronic low back pain. Am Fam Physician 91:708–714PubMed
16.
go back to reference Poddubnyy D, van Tubergen A, Landewé R, Sieper J, van der Heijde D, Assessment of SpondyloArthritis international Society (ASAS) (2015) Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis. Ann Rheum Dis 74:1483–1487CrossRefPubMed Poddubnyy D, van Tubergen A, Landewé R, Sieper J, van der Heijde D, Assessment of SpondyloArthritis international Society (ASAS) (2015) Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis. Ann Rheum Dis 74:1483–1487CrossRefPubMed
17.
go back to reference Cherkin DC, Deyo RA, Volinn E, Loeser JD (1992) Use of the International Classification of Diseases (ICD-9-CM) to identify hospitalizations for mechanical low back problems in administrative databases. Spine (Phila Pa 1976) 17:817–825CrossRef Cherkin DC, Deyo RA, Volinn E, Loeser JD (1992) Use of the International Classification of Diseases (ICD-9-CM) to identify hospitalizations for mechanical low back problems in administrative databases. Spine (Phila Pa 1976) 17:817–825CrossRef
18.
go back to reference van der Heijde D, Sieper J, Elewaut D, Deodhar A, Pangan AL, Dorr AP (2014) Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international survey. J Clin Rheumatol 20:411–417CrossRefPubMedPubMedCentral van der Heijde D, Sieper J, Elewaut D, Deodhar A, Pangan AL, Dorr AP (2014) Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international survey. J Clin Rheumatol 20:411–417CrossRefPubMedPubMedCentral
19.
go back to reference Põlluste K, Kallikorm R, Meiesaar K, Lember M (2012) Use of general practice and rheumatology outpatient services in rheumatoid arthritis. Fam Pract 29:433–440CrossRefPubMed Põlluste K, Kallikorm R, Meiesaar K, Lember M (2012) Use of general practice and rheumatology outpatient services in rheumatoid arthritis. Fam Pract 29:433–440CrossRefPubMed
20.
go back to reference Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Ivers N et al (2014) Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system. BMJ Open 4:e003888CrossRefPubMedPubMedCentral Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Ivers N et al (2014) Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system. BMJ Open 4:e003888CrossRefPubMedPubMedCentral
21.
go back to reference Hamilton L, Gilbert A, Skerrett J, Dickinson S, Gaffney K (2011) Services for people with ankylosing spondylitis in the UK—a survey of rheumatologists and patients. Rheumatology (Oxford) 50:1991–1998CrossRef Hamilton L, Gilbert A, Skerrett J, Dickinson S, Gaffney K (2011) Services for people with ankylosing spondylitis in the UK—a survey of rheumatologists and patients. Rheumatology (Oxford) 50:1991–1998CrossRef
22.
go back to reference Feldtkeller E, Braun J (2000) Impact of sex on inheritance of ankylosing spondylitis [letter]. Lancet 355:1096–1097CrossRefPubMed Feldtkeller E, Braun J (2000) Impact of sex on inheritance of ankylosing spondylitis [letter]. Lancet 355:1096–1097CrossRefPubMed
23.
go back to reference Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–ii44CrossRefPubMed Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–ii44CrossRefPubMed
24.
go back to reference Aggarwal R, Malaviya AN (2009) Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes—an Indian perspective. Clin Rheumatol 28:327–331CrossRefPubMed Aggarwal R, Malaviya AN (2009) Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes—an Indian perspective. Clin Rheumatol 28:327–331CrossRefPubMed
Metadata
Title
Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay
Authors
Atul Deodhar
Manish Mittal
Patrick Reilly
Yanjun Bao
Shivaji Manthena
Jaclyn Anderson
Avani Joshi
Publication date
01-07-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3231-z

Other articles of this Issue 7/2016

Clinical Rheumatology 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine